Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Genetronics Announces Return of Rights From Ethicon Endo-Surgery.
- SAN DIEGO, Jul 26, 2000 Genetronics Biomedical Limited, San Diego, (Amex: GEB; Toronto) announced today that Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, has elected to exercise its discretionary right to terminate without cause the Licensing and Development Agreement and the Supply ...
- Research articles 2000-07-27
Additional Resources
- Genetronics launches Internet Web site
- SAN DIEGO--BUSINESS WIRE--Jan. 15, 1996--Genetronics Biomedical Ltd. (VcSE:GEB) announced the introduction of its new Internet home page on the World Wide Web.Genetronics' Internet address is http://www.genetronics.com.Visitors to Genetronics' Web site may access on-line information, including the company's most recent annual report, the BTX Instrument Division product line, the Electronic Genetics...
- Research articles 1996-01-15
- Genetronics receives SBIR grant from the National Heart, Lung, and Blood Institute; total SBIR funding more than $1 million
- SAN DIEGO--BUSINESS WIRE--Sept. 17, 1996--Genetronics Biomedical Ltd. (VSE:GEB) announced that it has received a Phase I Small Business Innovation Research SBIR grant from the National Heart, Lung, and Blood Institute in the amount of $95,468.Dr. Ken Dev, Genetronics' director of research, is the principal investigator of the funded study titled...
- Research articles 1996-09-17
- Merck and Genetronics Shake Hands on DNA Delivery (Drug Discovery and Development)
- Merck Co. Inc., Whitehouse Station, N.J., is gambling on an old technology to overcome obstacles in delivering new DNA vaccines. The global pharmaceutical company has recently signed an agreement with Genetronics Biomedical Corp., San Diego, to lice Merck Co. Inc., Whitehouse Station, N.J., is gambling...
- Research articles 2004-08-01
- Genetronics' President and CEO to Present at Wells Fargo's 2005 Healthcare Conference
- SAN DIEGO -- Genetronics Biomedical Corporation (AMEX:GEB), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that Avtar Dhillon, MD, President and CEO, will present a corporate overview on the Company at Wells Fargo Securities' 2005 Healthcare Conference on Tuesday,...
- Research articles 2005-02-25
- Genetronics Appoints Director.
- SAN DIEGO, Oct 03, 2000 Genetronics Biomedical Limited, San Diego, (Amex: GEB; Toronto) today announced that Tazdin Esmail, President and Chief Executive Officer of Forbes Medi-Tech Inc., (Nasdaq: FMTI; Toronto: FMI), Vancouver, British Columbia has been named to its Board of Directors. ...
- Research articles 2000-10-03
- Merck Exercises Option for Additional Antigen for Use with Inovio Biomedical's MedPulser DNA Delivery System
- SAN DIEGO -- Inovio Biomedical Corporation (AMEX:INO) announced today that Merck & Co., Inc. (NYSE:MRK) has exercised an option for a non-exclusive license for an additional antigen to be used with Inovio's MedPulserR DNA Delivery System, which is being developed for use with certain of Merck's DNA vaccine research programs....
- Research articles 2005-05-12
- Investors to Hear From Companies Including Beckman Coulter, Nektar Therapeutics & BioMarin Pharmaceutical at Biotechnology & Healthcare Stocks Forum in Foster City, CA on Dec. 7
- SAN FRANCISCO -- SCOLR, Genetronics Biomedical, and Lorus Therapeutics also to present with John McCamant, Editor of The Medical Technology Stock Letter, Delivering the Keynote
- Research articles 2004-11-18
- Biotech Market Movers: PWRM, GEB, IDBE, LCBM, PCOP.
- M2 PRESSWIRE-1 July 2004-InvestSource Inc.: Biotech Market Movers: PWRM, GEB, IDBE, LCBM, PCOPC1994-2004 M2 COMMUNICATIONS LTD RDATE:07012004 Stocks in the News: Power 3 Medical Products Incorporated (OTCBB: PWRM), Genetronics Biomedical Corporation (AMEX: GEB), ID Biomedical Corporation (NASDAQ: IDBE), Lifecore Biomedical Incorporated...
- Research articles 2004-07-01
- Inovio Biomedical Corp. bouncing back from shaky past, facing critical year: company raises $15.5m in sale of stock, gains $1.1m grant from U.S. Department of Defense
- If Avtar Dhillon has his way, history won't repeat itself. Twenty-three years ago, Inovio Biomedical Corp. was born--albeit three names and four chief executive officers ago. Mergers and acquisitions abound in the biotechnology industry, making the long-standing company a small wonder. The former Genetronics Biomedical Corp. almost folded...
- Research articles 2006-11-06
- REPEAT/Corporate Profile for Genetronics Biomedical Ltd., dated Oct. 20, 1995
- --BUSINESS WIRE--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services.These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog,...
- Research articles 1995-10-24
- Corporate Profile for Genetronics Biomedical Ltd., dated Oct. 20, 1995
- --BUSINESS WIRE--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services.These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog,...
- Research articles 1995-10-20
- REPEAT/Corporate Profile for Genetronics Biomedical Ltd., dated Oct. 20, 1995
- --BUSINESS WIRE--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services.These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog,...
- Research articles 1995-11-28
- Health care and biotech
- Stressgen Biotechnologies has appointed Bruce Berger to vice president of clinical development and Howard T. Holden to vice president, regulatory affairs and compliance. Peter Kies has been appointed chief financial officer at Genetronics Biomedical Corp. William H. Baum has been promoted to executive vice president of Diversa Corp.
- Research articles 2002-07-29
- << Previous
- page 1 of 1
- Next >>
